Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-26

Clinical Trial Update: A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children [Phase 3]

View source ↗

Summary

A Phase III trial of an oral recombinant Helicobacter pylori vaccine in Chinese children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral recombinant Helicobacter pylori vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: H. Pylori Infection | Phase 3 | Status: COMPLETED